Is Avantor Inc (AVTR) overvalued? · P/E 13, rev $6.55B
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
This page asks whether Avantor Inc (AVTR) looks expensive on cached numbers — not a short thesis.
Latest reported AVTR revenue for 2025-12-31 was $6.55B. Net income was -$530.2M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AVTR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AVTR stock page for the full model, not this heading.
Not investment advice.